Interaction Of Tgf-Beta 1 And Ionizing Radiation In An In Vitro Wound Healing Model: Rho Kinase-Mediated Inhibition Of Fibroblast Migration And Implications For Iort
L. Ma,C. Kettner,F. Wenz,C. Herskind
DOI: https://doi.org/10.1016/j.ijrobp.2011.06.1355
2011-01-01
Abstract:Purpose/Objective(s)Intraoperative radiotherapy (IORT) involves wound healing in tissue after a large single dose of radiation. However, the interaction between the radiation and wound healing responses is not well understood. Transforming growth factor (TGF)-β1 is released after irradiation in vivo, and is also an important mediator of wound healing. The purpose was to study the effects of TGF-β1 and irradiation on migration of fibroblasts in an in vitro wound healing assay.Materials/MethodsPrimary human skin fibroblasts (GS4) were used in early passage. Fibroblast migration was studied in response to wounding density-arrested or sparse cultures using a scratch assay. The role of Rho kinase (ROCK) and Rho was tested by inhibiting their function with Y-27632 and Pravastatin, respectively. Expression of the TGF-β1 downstream effector, connective tissue growth factor (CTGF/CCN2), was detected by Western blot. The myofibroblast marker, α-smooth muscle actin (α-sma), was detected by immunofluorescence microscopy. Irradiations were performed with 6 MV x rays.ResultsScratch wounds in sparse, exponentially growing cultures closed within 12 - 24 h whereas closure required at least 48 h in density-arrested cultures. However, wound closure was not inhibited by irradiation with 4 - 12 Gy, instead a small trend for stimulation was observed. Thus wound closure was caused by migration rather than by proliferation. 1 - 10 ng/ml TGF-β1 inhibited the rate of wound closure in a concentration-dependent manner with no further effect of 30 - 100 ng/ml. The ROCK inhibitor Y-27632 partly reversed the TGF-β1-induced inhibition of fibroblast migration, implicating ROCK in mediating the inhibitory TGF-β1 signal. 500 μM Pravastatin (= ED50) inhibited fibroblast migration in its own right. Presumably, reversal of inhibition could not be detected owing to inhibition of RhoA and Rac which are directly required for cell motility. Early induction of CTGF/CCN2 by TGF-β1 was inhibited by Pravastatin or Y-27632. Marked upregulation of α-sma by TGF-β1 occurred only after closure of the in vitro wound.ConclusionsThe results suggest that TGF-β1-induced inhibition of fibroblast migration in response to wounding is mediated by the Rho/ROCK pathway. A likely downstream target is activation of LIM kinase and inhibition of cofilin activity, resulting in increase stress fiber formation and reduced migration. Conceivably fibroblast differentiation via CTGF/CCN2 may contribute. The finding that radiation has no adverse effect on or even stimulates migration whereas TGF-β1 is inhibitory suggests that the timing of TGF-β1 release after irradiation and during wound healing may be an important factor in successful wound healing after IORT. Purpose/Objective(s)Intraoperative radiotherapy (IORT) involves wound healing in tissue after a large single dose of radiation. However, the interaction between the radiation and wound healing responses is not well understood. Transforming growth factor (TGF)-β1 is released after irradiation in vivo, and is also an important mediator of wound healing. The purpose was to study the effects of TGF-β1 and irradiation on migration of fibroblasts in an in vitro wound healing assay. Intraoperative radiotherapy (IORT) involves wound healing in tissue after a large single dose of radiation. However, the interaction between the radiation and wound healing responses is not well understood. Transforming growth factor (TGF)-β1 is released after irradiation in vivo, and is also an important mediator of wound healing. The purpose was to study the effects of TGF-β1 and irradiation on migration of fibroblasts in an in vitro wound healing assay. Materials/MethodsPrimary human skin fibroblasts (GS4) were used in early passage. Fibroblast migration was studied in response to wounding density-arrested or sparse cultures using a scratch assay. The role of Rho kinase (ROCK) and Rho was tested by inhibiting their function with Y-27632 and Pravastatin, respectively. Expression of the TGF-β1 downstream effector, connective tissue growth factor (CTGF/CCN2), was detected by Western blot. The myofibroblast marker, α-smooth muscle actin (α-sma), was detected by immunofluorescence microscopy. Irradiations were performed with 6 MV x rays. Primary human skin fibroblasts (GS4) were used in early passage. Fibroblast migration was studied in response to wounding density-arrested or sparse cultures using a scratch assay. The role of Rho kinase (ROCK) and Rho was tested by inhibiting their function with Y-27632 and Pravastatin, respectively. Expression of the TGF-β1 downstream effector, connective tissue growth factor (CTGF/CCN2), was detected by Western blot. The myofibroblast marker, α-smooth muscle actin (α-sma), was detected by immunofluorescence microscopy. Irradiations were performed with 6 MV x rays. ResultsScratch wounds in sparse, exponentially growing cultures closed within 12 - 24 h whereas closure required at least 48 h in density-arrested cultures. However, wound closure was not inhibited by irradiation with 4 - 12 Gy, instead a small trend for stimulation was observed. Thus wound closure was caused by migration rather than by proliferation. 1 - 10 ng/ml TGF-β1 inhibited the rate of wound closure in a concentration-dependent manner with no further effect of 30 - 100 ng/ml. The ROCK inhibitor Y-27632 partly reversed the TGF-β1-induced inhibition of fibroblast migration, implicating ROCK in mediating the inhibitory TGF-β1 signal. 500 μM Pravastatin (= ED50) inhibited fibroblast migration in its own right. Presumably, reversal of inhibition could not be detected owing to inhibition of RhoA and Rac which are directly required for cell motility. Early induction of CTGF/CCN2 by TGF-β1 was inhibited by Pravastatin or Y-27632. Marked upregulation of α-sma by TGF-β1 occurred only after closure of the in vitro wound. Scratch wounds in sparse, exponentially growing cultures closed within 12 - 24 h whereas closure required at least 48 h in density-arrested cultures. However, wound closure was not inhibited by irradiation with 4 - 12 Gy, instead a small trend for stimulation was observed. Thus wound closure was caused by migration rather than by proliferation. 1 - 10 ng/ml TGF-β1 inhibited the rate of wound closure in a concentration-dependent manner with no further effect of 30 - 100 ng/ml. The ROCK inhibitor Y-27632 partly reversed the TGF-β1-induced inhibition of fibroblast migration, implicating ROCK in mediating the inhibitory TGF-β1 signal. 500 μM Pravastatin (= ED50) inhibited fibroblast migration in its own right. Presumably, reversal of inhibition could not be detected owing to inhibition of RhoA and Rac which are directly required for cell motility. Early induction of CTGF/CCN2 by TGF-β1 was inhibited by Pravastatin or Y-27632. Marked upregulation of α-sma by TGF-β1 occurred only after closure of the in vitro wound. ConclusionsThe results suggest that TGF-β1-induced inhibition of fibroblast migration in response to wounding is mediated by the Rho/ROCK pathway. A likely downstream target is activation of LIM kinase and inhibition of cofilin activity, resulting in increase stress fiber formation and reduced migration. Conceivably fibroblast differentiation via CTGF/CCN2 may contribute. The finding that radiation has no adverse effect on or even stimulates migration whereas TGF-β1 is inhibitory suggests that the timing of TGF-β1 release after irradiation and during wound healing may be an important factor in successful wound healing after IORT. The results suggest that TGF-β1-induced inhibition of fibroblast migration in response to wounding is mediated by the Rho/ROCK pathway. A likely downstream target is activation of LIM kinase and inhibition of cofilin activity, resulting in increase stress fiber formation and reduced migration. Conceivably fibroblast differentiation via CTGF/CCN2 may contribute. The finding that radiation has no adverse effect on or even stimulates migration whereas TGF-β1 is inhibitory suggests that the timing of TGF-β1 release after irradiation and during wound healing may be an important factor in successful wound healing after IORT.